Compare
Lilly (Eli) vs McKesson (LLY vs MCK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Lilly (Eli) (LLY) returned +46.2% and McKesson (MCK) +25.6%; so far this year the figures are +26.0% and +29.3%.
Lilly (Eli) is the larger company by market value, about 10.4 times the size of McKesson.
On trailing earnings, LLY trades at 43.9 times and MCK at 27.3 times.
Revenue grew +45.5% at LLY and +8.2% at MCK over the last year.
LLY yields 0.49%. MCK yields 0.32%.
Data as of the latest close. Not investment advice.
Relative performance
| LLY | MCK | |
|---|---|---|
| Price | $1,354.00 | $1,060.84 |
| 1-day | -0.79% | -1.04% |
| YTD | +25.99% | +29.32% |
| 1 year | +46.25% | +25.65% |
| 3 years | +144.20% | +130.82% |
| Market cap | $1.27T | $122.5B |
| P/E | 43.9 | 27.3 |
| P/S | 14.73 | 0.29 |
| P/B | 31.63 | — |
| Revenue growth | +45.50% | +8.20% |
| EPS growth | +50.70% | +21.20% |
| Gross margin % | 83.6 | 3.7 |
| Net margin % | 31.9 | 1.1 |
| ROE % | 68.5 | — |
| Debt / equity | 1.23 | — |
| FCF yield % | 2.4 | 5.8 |
| Dividend yield % | 0.49 | 0.32 |
| Beta | 0.29 | -0.17 |
| RSI (14) | 61.1 | 70.2 |
| Technical rating |